- Home
- TXN vs MRK Comparison
TXN vs MRK Comparison
Compare TXN & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TXN | MRK |
|---|---|---|
| Founded | 1930 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 256.7B | 268.7B |
| IPO Year | 2002 | 1994 |
Fundamental Metrics
Financial Performance| Metric | TXN | MRK |
|---|---|---|
| Price | $322.36 | $113.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 25 | 17 |
| Target Price | ★ $265.46 | $125.59 |
| AVG Volume (30 Days) | 7.2M | ★ 8.3M |
| Earning Date | 04-22-2026 | 04-30-2026 |
| Dividend Yield | 2.11% | ★ 3.06% |
| EPS Growth | 4.81 | ★ 8.01 |
| EPS | ★ 1.68 | N/A |
| Revenue | $17,682,000,000.00 | ★ $65,011,000,000.00 |
| Revenue This Year | $11.74 | $3.61 |
| Revenue Next Year | $10.43 | $5.41 |
| P/E Ratio | $179.44 | ★ N/A |
| Revenue Growth | ★ 13.05 | 1.31 |
| 52 Week Low | $152.73 | $76.66 |
| 52 Week High | $331.51 | $125.14 |
Technical Indicators
Market Signals| Indicator | TXN | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 61.08 | 43.47 |
| Support Level | $178.20 | $112.96 |
| Resistance Level | $331.51 | $123.93 |
| Average True Range (ATR) | 11.58 | 2.99 |
| MACD | -0.28 | -0.60 |
| Stochastic Oscillator | 98.18 | 21.57 |
Price Performance
Historical ComparisonAbout TXN Texas Instruments Incorporated
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).